AzTrials
AzTrials

Vaccine RefusalNCT05648513

The Motivational Interview Teqhnique in Pregnant Women Who Are Hesitant in Childhood Vaccines

A study testing Motivational Interwiev in people with Vaccine Refusal and Pregnancy Related, run by Balikesir University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Vaccine hesitancy is defined by World Health Organization(WHO) "Vaccine Hesitancy Working Group" as a delay in acceptance or refusal of vaccines despite availability of vaccination services(MacDonald,2015). Read more about this study

Who is it for?
Ages 18 to 49 years, women onlyHealthy volunteers can take part
Conditions the study is for
Vaccine Refusal, Pregnancy Related, Motivation
What is being tested?
Motivational Interwiev
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
1 siteTurkey (Türkiye)
Study dates
28 Dec 2022to 1 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 49 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Being pregnant for 28+ weeks,
  • Experiencing hesitancy about childhood vaccines,
  • Agreeing to participate in the study,
  • Being literate,
  • Having no communication disability,
  • Volunteering to participate in the study,

Who cannot join

  • Having high risk pregnancy
  • Having psychiatric diseases
  • Adolescent pregnancy
  • Not accepting to participate in the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Balikesir University

    Balıkesir, 10145

    Selda Yörük, Dr., +905052674422, seldayoruk@gmail.com

    Selda Yoruk, Dr., +905052674422, seldayoruk@gmail.com

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of the Motivational Interview Teqhnique in Pregnant Women Who Are Hesitant in Applying Childhood Vaccines

Vaccine hesitancy is defined by World Health Organization(WHO) "Vaccine Hesitancy Working Group" as a delay in acceptance or refusal of vaccines despite availability of vaccination services(MacDonald,2015). WHO listed "vaccine hesitancy" as one of the ten global health threats that require immediate solution in 2019(WHO, 2019). It was found out that the primary causes of vaccine hesitancy are the risk-benefit ratio concerns, including "concerns about the safety of vaccines" or "their potential side-effects", and secondary causes are the lack of information and awareness about vaccines and their importance and religious, cultural, social gender and socioeconomic perceptions of vaccination(Lark et al., 2018).It is estimated in social studies that the prevalence of vaccine hesitancy is about 25-70% in the top-ranking France, 15% in Switzerland and 19% in Canada(Ward et al.,2019; Shen and Dubey,2019). In the case of pregnant women, on the other hand, childhood vaccine hesitancy has been detected to vary between 6% and 12%(Mohd et al.,2017; Corben and Leask,2018).

There is a critical increase in the number of unvaccinated children in Turkey(Turkish Medical Association, 2018).Based on the data from Ministry of Health, number of families that refused to get their children vaccinated rose from 183 in 2011 to 12000 in 2016, and to 23600 in 2017(Turkish Medical Association, 2018).

Read more

Motivation is the probability of the individual to adopt, continue and adhere to the special strategies of change.MI is a directive and counselee-oriented approach, which is employed to help the patients explore and overcome the ambivalence/dilemma in adopting the behaviors that will enhance and improve their overall health.

Studies conducted in recent years have found out that motivational interviewing technique is actually effective in parents' acceptance of childhood vaccines. The main purpose of the MI technique is to explore the ambivalences of the target individuals and attain behavioral change by helping them overcome such ambivalences. This method is particularly useful with parents that are hesitant or ambivalent to get their children vaccinated, or those that fail to get them vaccinated. In MI, which focuses on the parents' concerns, questions and curiosities about the vaccines, the behavioral change takes place depending on the personal values of each individual. MI is a special means of aid to help individuals understand their problems and encourage them to take action(Danchin et al.,2017).

In order to enhance vaccination services, studies must be conducted on the issue of vaccine opposition and hesitancy of families, and underlying reasons must be revealed(Topçu et al.,2019; Akbaş,2020). Due to the fact that pregnancy and antenatal periods are the time spans when the first perspectives and beliefs about childhood vaccination are formed, these periods are particularly important for providing information pediatric vaccines. Determining the prevalence of vaccine opposition within the society, and monitoring it in upcoming years, as well as making programs on inspection and education, are assumed to be crucial in the struggle with vaccine hesitancy.

This study is particularly important as it will help eradicate vaccine hesitancy through using Motivational Interviewing (MI) method and revealing the ambivalent emotions about vaccine hesitancy in pregnant women.

Read the detailed description

Main hypotheses/goal of the Study:

Hypothesis 0 Motivational Interviewing has no effect on vaccine hesitant pregnant women.

Hypothesis 1 Motivational Interviewing is effective on vaccine hesitant pregnant women.

Objective of the Study The study is a randomized experimental work conducted to analyze the effectiveness of Motivational Interviewing Method on pregnant women experiencing hesitancy about childhood vaccines.

Study Area:

The study will be conducted during March 2022-March 2023 in Balıkesir province. Balıkesir is located in the Southern Marmara sub-region, some of its land extending to Aegean Region. It is surrounded by Bursa and Kütahya to the east, Manisa and İzmir to the south, and Çanakkale to the west. The province is composed of 20 districs, 2 of them being the central districts. As per the 2020 findings of Turkish Statistical Institute (TUIK), it has a population of 1 240 285 people living in a total land area of 14 292 square kilometers. The main sources of income are agriculture and farming.

Planned data collection centers: Pregnant women visiting Atatürk Şehir Hastanesi (lit.Atatürk City Hospital) will be invited to participate in the research study.

Criteria to terminate the study:

The study will be terminated if it cannot be implemented due to reasons including disease and pandemic.

MATERIAL AND METHOD OF THE STUDY:

Population of the Study and sampling The population of the study comprises pregnant women residing in Balıkesir. Sampling size was calculated based on greater effect size in the intervention phase of the study. Using G-Power program, and given that α=0.05, power=0.95, effect size=0.80 according to bi-directional hypothesis, the sampling size was calculated to be 52 (control group: 26 and experimental group: 26)

Criteria for participation in the research study:

  • Being pregnant for 28+ weeks,
  • Experiencing hesitancy about childhood vaccines,
  • Agreeing to participate in the study,
  • Being literate,
  • Having no communication disability,
  • Volunteering to participate in the study,

Criteria for exclusion from the research study:

  • Having high risk pregnancy
  • Having psychiatric diseases
  • Adolescent pregnancy
  • Not accepting to participate in the study Data collection technique Parent Attitudes About Childhood Vaccines Survey (PACV) will be implemented to the patients consulting to Atatürk City Hospital. Subjects with vaccine hesitancy will be randomly distributed to groups, and in this way, experimental (n=26) and control (n=26) groups will be formed. Routine antenatal monitoring will be kept with the control group. With the experimental group, on the other hand, motivational interviewing method will be implemented for 4 sessions of about 45 minutes each. Interviews will be held at 4 separate weekends, 1 session for each. Interviews will be performed via online means or face to face.

Implementation Sessions of Motivational Interviewing Method is presented in Table 1 and Flowchart of the Study is Presented in Figure 1.

Table 1. Implementation Sessions of Motivational Interviewing Method

Sessions Contents

  1. st Session (Week 1) - Acquaintance
  • Informing the individual about the interview (frequency/duration)
  • Revealing the rate of knowledge and attitudes of the individuals about vaccination
  • Identifying the reasons of vaccine hesitancy
  • Providing required information about vaccines
  1. nd Session (Week 2) -Evaluation of the previous session
  • Reinforcement of motivation
  • Implementation of significance and reliability scale
  • Revealing the dilemma about vaccines
  1. rd Session (Week 3) -Evaluation of the previous session
  • Reinforcement of motivation
  • Implementation of bidirectional decision balance
  • Evaluation of the "change" speech of the subject
  • If the change speech is evident, drafting transformation plan
  1. th Session (Week 4) -Evaluation of the previous session
  • If ambivalence continues with the subject, speech on vaccination and stress on the importance of self- control
  • Reviewing the change plan, if it has been drawn up in previous session
  • Reinforcement of the sustainability of attained changes
  • Evaluation

Figure 1. Flow Chart of the Study

  • Identification of pregnant women with vaccine hesitation (n=52)

Randomization (n=52)

  • ↘ Control Group Experimental Group ( n=26 ) (n=26)
  • ↓ ↓ Routine antenatal monitoring Completion of motivational interviewing session
  • ↓ ↓ Inspection of the vaccine card 1st and 2nd postnatal months and implementation of Parent Attitudes About Childhood Vaccines Survey (PACV)

Personal Details Form It is the survey form that includes such socio-demographic aspects of the participants as their ages and educational backgrounds, and their opinions about vaccines.

Parent Attitudes About Childhood Vaccines Survey (PACV) It is a 10-point Likert scale; points 1-5 indicating hesitant response, points 6 and 7 uncertain response, and points 8-10 unhesitant response. Hesitant responses are assigned a 2, 'don't know or not sure' a 1, and non-hesitant responses a 0. After attributing points for each item, item scores are summed to obtain a total raw score. The total raw score was then converted to a scale ranging from 0 (least hesitant) to 100 (most hesitant), using simple linear transformation, Parents with a converted score ≥ 50 are identified as vaccine hesitant parents, while those with a converted score < 50 are identified as non-hesitant parents (Mutlu, 2021).

Variables of the Research Study Dependent variable: Vaccine hesitancy scores of the participants Independent Variable: Sociodemographic aspects of the participants (age, education, income etc.), pregnancy-derived aspects (week of pregnancy, planned or unplanned pregnancy etc.), implementation of MI Data Analysis Data will be analyzed on computer environment using SPSS 25 package software. Statistical significance will be accepted if p<0.05. In statistical analysis of the data, frequency and percentage values will be used for nominal data, whereas medians and standard deviation values will be used for numerical data. Normal distribution of the data will be assessed through Kolmogorov-Smirnov test. Univariate analysis and multivariate analysis methods and chi square test will be used in comparison of the nominal values across the two groups.

Being tested
Motivational Interwiev
Keywords
Motivational interviewing, vaccine,vaccine hesitancy
Medical subject headings
Vaccination Refusal, Vaccination Hesitancy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motivational InterwievBehavioural

    Parent Attitudes About Childhood Vaccines Survey (PACV) will be implemented to the patients consulting to Atatürk City Hospital. Subjects with vaccine hesitancy will be randomly distributed to groups, and in this way, experimental (n=26) and control (n=26) groups will be formed. Routine antenatal monitoring will be kept with the control group. With the experimental group, on the other hand, motivational interviewing method will be implemented for 4 sessions of about 45 minutes each. Interviews will be held at 4 separate weekends, 1 session for each. Interviews will be performed via online means or face to face.

Study groups in NCT05648513
Study groupRoleWhat they receive
Motivational InterviewExperimentalParent Attitudes About Childhood Vaccines Survey (PACV) will be implemented to the pregnant women consulting to Atatürk City Hospital. Subjects with vaccine hesitancy will be randomly distributed to groups, and in this way, experimental (n=26) and control (n=26) groups will be formed. Routine antenatal monitoring will be kept with the control group. With the experimental group, on the other hand, motivational interviewing method will be implemented for 4 sessions of about 45 minutes each. Interviews will be held at 4 separate weekends, 1 session for each. Interviews will be performed via online means or face to face. Personal Details Form It is the survey form that includes such socio-demographic aspects of the participants as their ages and educational backgrounds, and their opinions about vaccines.
Receives: Behavioral: Motivational Interwiev
Control GroupNo interventionControl Group Experimental Group ( n=26 ) Routine antenatal monitoring will be kept with the control group. Routine antenatal monitoring Completion of motivational interviewing session Inspection of the vaccine card 1st and 2nd postnatal months and implementation of Parent Attitudes About Childhood Vaccines Survey (PACV) Personal Details Form It is the survey form that includes such socio-demographic aspects of the participants as their ages and educational backgrounds, and their opinions about vaccines.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Administered childhood vaccine

    Inspection of the vaccine card 1st and 2nd postnatal months and

    Measured: 6 months

  2. Vaccine Hesitant Score

    implementation of Parent Attitudes About Childhood Vaccines Survey (PACV)

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Dec 2022
  2. Study start28 Dec 2022 (estimated)
  3. Primary completion1 Apr 2023 (estimated)
  4. Study completion1 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05648513
Sponsor's protocol ID
BAÜNSBF-ARSLAN-001
Status last verified
Dec 2022
First submitted
5 Dec 2022
Last updated
13 Dec 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Motivational Interwiev in people with Vaccine Refusal and Pregnancy Related, run by Balikesir University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Administered childhood vaccine (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in